Marissa Antonio was just 39 years old when she was diagnosed with liver cancer - a disease that is the fastest rising cancer ...

Histological section of an FLC tumor, showing the stromal (left), normal (center), and tumor (right) cells. The colors correspond to gene markers ...

The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...

For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with the ...

The quantitative effects of alcohol consumption on cirrhosis and hepatocellular carcinoma (HCC) in hepatitis B virus (HBV) infection are unknown.

Researchers examined survival outcomes based on recipient-donor sex constellation after liver transplant for liver cancer.

SBRT showed superiority over radiofrequency ablation in local progression-free survival and tumor control in small HCC but ...

With better risk stratification, clinicians may be able to optimize medical management of patients with chronic HBV who don’t ...

CURE spoke with an expert about the potential positive effects of radiation therapy for patients with hepatocellular carcinoma.

Adding durvalumab and bevacizumab to transarterial chemoembolization improved responses and progression-free survival.

The following is a summary of “Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).